News

Your contact person

Manager PR & Communications Jan Phillip Denkers

The large and lively “HALRIC family” gathered in Lund in February to recap the three amazing years of the project and look ahead to the future. (Photo: HALRIC)
The large and lively “HALRIC family” gathered in Lund in February to recap the three amazing years of the project and look ahead to the future. (Photo: HALRIC)

HALRIC Strengthens Life Science Connections in Northern Europe

After three years, Life Science Nord has issued a positive assessment of the Interreg project HALRIC – Hanseatic Life Science Research Infrastructure Consortium. The project’s ...

Read more …
Dr. Fernando Delgado (CTO), Dr. Michael Hartung (CPO), Alexander Zahn (CEO), and Prof. Dr. Jan Baumbach (CSO) (from left) founded the company in Hamburg in 2025. (Photo: Galagos)
Dr. Fernando Delgado (CTO), Dr. Michael Hartung (CPO), Alexander Zahn (CEO), and Prof. Dr. Jan Baumbach (CSO) (from left) founded the company in Hamburg in 2025. (Photo: Galagos)

#NEWatLSN: Galagos

We are delighted to welcome Galagos as a new member of Life Science Nord e.V.! The founding team answered questions about the company’s initial goals, ...

Read more …
The meetings brought together senior representatives from the European Commission and multiple Member States. (Picture: HALRIC)
The meetings brought together senior representatives from the European Commission and multiple Member States. (Picture: HALRIC)

HALRIC in Brussels

Through direct dialogue with the European Commission and Member States, HALRIC’s Brussels discussions showed how cross-border life science collaboration can unlock efficiency, strengthen European competitiveness, ...

Read more …
Biotech and pharmaceutical companies will now have exclusive access to NexMR’s photo-induced NMR through CrystalsFirst, benefiting from the synergy of two advanced platforms working in tandem.v
Biotech and pharmaceutical companies will now have exclusive access to NexMR’s photo-induced NMR through CrystalsFirst, benefiting from the synergy of two advanced platforms working in tandem. (Image: unsplash/D koi)

NexMR joins forces with CrystalsFirst

CrystalsFirst GmbH, a leader in high-performance structural biology services, and NexMR AG, a pioneer in ultrafast NMR screening, today announced an exclusive partnership to accelerate ...

Read more …
Indivumed and Aptila join forces in a new proteomics collaboration. (Photo: Indivumed)
Indivumed and Aptila join forces in a new proteomics collaboration. (Photo: Indivumed)

Indivumed announces collaboration utilizing Aptila’s proteomics expertise

Indivumed is pleased to announce a close working relationship with Aptila as of August 2025. Aptila’s software suite, DIA-NN, is a leading solution for data-independent ...

Read more …
10,000 m² of contract logistics space for medical technology and reagents (Photo: Sysmex/Kuehne+Nagel)
10,000 m² of contract logistics space for medical technology and reagents (Photo: Sysmex/Kuehne+Nagel)

Kuehne+Nagel: New distribution centre for Sysmex

Kuehne+Nagel has opened a new distribution centre for Sysmex Europe SE and Sysmex Deutschland GmbH, dedicated to diagnostic instruments and reagents. As part of its ...

Read more …
The NIHR is the UK’s largest public funder of health and care research. (Image: NIHR)
The NIHR is the UK’s largest public funder of health and care research. (Image: NIHR)

A new strategic collaboration

A new strategic collaboration between life science clusters from Northern Europe and the UK’s National Institute for Health and Care Research (NIHR) is set to ...

Read more …
GQ Bio is pioneering a high-capacity adenovirus (HCAd) gene therapy vector platform that addresses some of the big challenges in the gene therapy field. (Picture: GQ Bio)
GQ Bio is pioneering a high-capacity adenovirus (HCAd) gene therapy vector platform that addresses some of the big challenges in the gene therapy field. (Picture: GQ Bio)

Pacira BioSciences Acquires GQ Bio

HTGF portfolio company GQ Bio, pioneering a high-capacity adenovirus gene therapy vector platform, was acquired by Pacira BioSciences, Inc. Pacira, the industry leader in its ...

Read more …
At its new premises in the tecHHub Hamburg, CrystalsFirst is significantly expanding its operations to foster greater synergy. (Picture: CrystalsFirst)
At its new premises in the tecHHub Hamburg, CrystalsFirst is significantly expanding its operations to foster greater synergy. (Picture: CrystalsFirst)

CrystalsFirst Scales Operations...

CrystalsFirst, a leading provider of advanced structural biology solutions and AI-driven drug discovery, is pleased to announce a multi-million-euro expansion of its laboratory infrastructure and ...

Read more …
medac has received FDA approval for treosulfan (Copyright Adobe Stock - Nicolas Hermbach)

Strategic cornerstone for medac: FDA approves treosulfan for alloHSCT

medac has received FDA approval for treosulfan as a new drug application with orphan drug designation prior to allogeneic hematopoietic stem cell transplantation (alloHSCT) in ...

Read more …
To officially mark the occasion, Gerlind Bräuning, Ulrich Spengler, and Sönke Friedrichsen cut the symbolic red ribbon, supported by Jan Zimmermann and Ole Stumborg representing the altona Operations department. (Picture: altona Diagnostics)
To officially mark the occasion, Gerlind Bräuning, Ulrich Spengler, and Sönke Friedrichsen cut the symbolic red ribbon, supported by Jan Zimmermann and Ole Stumborg representing the altona Operations department. (Picture: altona Diagnostics)

Grand opening of new altona Diagnostics production site

In the fall of 2024, altona celebrated the grand opening of its new extraction chemistry production site located at Schnackenburgallee in Hamburg opposite the premises ...

Read more …